Robert Herfkens
Academic Appointments
- Professor, Radiology - Diagnostic Radiology
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Diagnostic Radiology 300 Pasteur Dr Stanford, CA 94305 Tel Work (650) 723-4733 Fax (650) 723-5795Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 723-4733Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Diagnostic Radiology
- Radiology
Administrative Appointments
- Associate Chair for Clinical Technology, Department of Radiology, Stanford University (2005 - present)
- Director of MRI, Department of Radiology, Stanford University (1990 - present)
- Director of Destination Digital (PACS–digital imaging transfer), Department of Radiology, Stanford University (2001 - present)
- Co-director of PET/CT, Department of Radiology, Stanford University (2002 - 2004)
Honors and Awards
- Lauterbur Award, Society of Computed Body Tomography and MR ('01,02,03,04, 2005,2009)
- Fellow, International Society of Magnetic Resonance in Medicine (2001)
- President, International Society of Magnetic Resonance in Medicine (1998-1999)
- Chair, Safety Committee, International Society of Magnetic Resonance in Medicine (1996-1997)
Professional Education
| Fellowship: | UCSF Medical Center CA (1980) |
| Fellowship: | UCSF Medical Center CA (1979) |
| Board Certification: | Diagnostic Radiology, American Board of Radiology (1979) |
| Board Certification: | Nuclear Radiology, American Board of Radiology (1980) |
| Residency: | UCSF Medical Center CA (1978) |
| Residency: | Loyola University Medical Center IL (1976) |
Graduate & Fellowship Program Affiliations
Community and International Work
- Multiple Committees, International
Scientific Focus
Current Research Interests
Imaging of cardiovascular diseases with CT, magnetic resonance imaging and spectroscopy
Clinical Trials
- Recruiting Magnetic Resonance Imaging of Breast Cancer
- Recruiting PET/CT and Whole-Body MRI for Detection of Skeletal and Soft Tissue Metastases
- Not Recruiting Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
- Not Recruiting Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
Publications
- 2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR Appropriate Utilization of Cardiovascular Imaging in Heart Failure: A Joint Report of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Foundation Appropriate Use Criteria Task Force. J Am Coll Cardiol. 2013; (21): 2207-31
- Evaluation of Marfan patients status post valve-sparing aortic root replacement with 4D flow. Magn Reson Imaging. 2013
- Improvement of gadoxetate arterial phase capture with a high spatio-temporal resolution multiphase three-dimensional SPGR-dixon sequence. J Magn Reson Imaging. 2013
- Pilot Prospective Evaluation of 99mTc-MDP Scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and Whole-Body MRI for Detection of Skeletal Metastases. Clin Nucl Med. 2013; (7): e290-6
- Respiratory-induced 3D deformations of the renal arteries quantified with geometric modeling during inspiration and expiration breath-holds of magnetic resonance angiography. J Magn Reson Imaging. 2013
- Intravaginal gel for staging of female pelvic cancers--preliminary report of safety, distention, and gel-mucosal contrast during magnetic resonance examination. J Comput Assist Tomogr. 2012 Mar-Apr; (2): 253-6
Help